Citing alleged safety and effectiveness concerns, the FDA revoked authorizations for both hydroxychloroquine and chloroquine at the request of Gary Disbrow, acting director of the Biomedical Advanced Research and Development Authority (BARDA).
According to FDA chief scientist Denise Hinton, the decision was made after reviewing supposed new information from large clinical trials. Based on this assessment, the FDA has decided that suggested dosing regimens of hydroxychloroquine "are unlikely to produce an antiviral effect," and will thus not be allowed even if patients still want to give the drug a try.
The left-wing media is, of course, supportive of the move. Politico, for instance, claims that hydroxychloroquine was approved for emergency use back in late March "despite thin evidence." It also still says that randomized controlled trials have shown no benefits and potential harm, which has already been debunked.
While doctors can still prescribe hydroxychloroquine "off label" for Wuhan coronavirus (COVID-19) patients, it could be difficult for many patients to actually find doctors who are willing to cooperate.
FDA says nobody can use hydroxychloroquine tablets donated by Bayer because they are not approved
As for what will become of the millions of hydroxychloroquine tablets that were donated to the United States by Bayer, the FDA has declared that because these are not officially approved for use in the country, they will have to be disposed of or returned.
Keep in mind that the FDA has never proposed any other solutions for the Wuhan coronavirus (COVID-19), and to this day has not suggested any alternatives. Hydroxychloroquine remains one of the only drug-based remedies that is both inexpensive, easily accessible, and anecdotally effective, if only the FDA would cooperate.
Rick Bright, the former director of BARDA who was replaced by Disbrow, was removed from his role after the Trump administration determined that he was only focused on pushing lucrative new drug treatments and vaccines, all the while bad-mouthing hydroxychloroquine for reasons that were obviously motivated by conflicts of interest.
Meanwhile, millions of doses of hydroxychloroquine are readily available and waiting in the strategic national stockpile after being donated by the drug industry, and the FDA is refusing to allow their use by American patients.
Perhaps the FDA missed the recent retraction of a bogus study published in the journal The Lancet that falsely claimed hydroxychloroquine is both unsafe and ineffective in Wuhan coronavirus (COVID-19) patients.
That study, which contained erroneous and falsified data, would appear to be among the "new research" that the FDA is now claiming justifies pulling hydroxychloroquine from its emergency use classification.
The irony is that if hydroxychloroquine really is unsafe and ineffective, then the FDA is to blame for it ever being approved in the first place. If the drug is so dangerous that desperate and suffering patients are no longer allowed to use it, then why is it still approved at all?
"There have been thousands of reports of this drug successfully fighting Covid19," wrote one Stat News commenter by the name of Dr. Jim Nichols.
"The negative studies were proven to be bogus or not combined with zinc or the proper antibiotics. This sounds like anti-Trump propaganda and may kill hundreds of people. Requires investigation."
"HCQ's antiviral action requires Zinc supplementation to work properly – this was shown in-vitro from the beginning," wrote another, emphasizing the fact that the FDA is completely ignoring the zinc component.
To keep up with the latest news about the Wuhan coronavirus (COVID-19), be sure to check out Pandemic.news.
Sources for this article include:
Please contact us for more information.
